Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline

J.D. Chalmers, I.F. Laska, F.M.E. Franssen, W. Janssens, I. Pavord, D. Rigau, M.J. McDonnell, N. Roche, D.D. Sin, D. Stolz, S. Suissa, J. Wedzicha, M. Miravitlles

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number2000351
Number of pages12
JournalEuropean Respiratory Journal
Volume55
Issue number6
DOIs
Publication statusPublished - 1 Jun 2020

Keywords

  • blood eosinophil count
  • double-blind
  • exacerbations
  • fluticasone furoate
  • obstructive pulmonary-disease
  • post-hoc analysis
  • risk
  • salmeterol-fluticasone
  • salmeterol/fluticasone
  • vilanterol
  • VILANTEROL
  • BLOOD EOSINOPHIL COUNT
  • RISK
  • FLUTICASONE FUROATE
  • SALMETEROL-FLUTICASONE
  • SALMETEROL/FLUTICASONE
  • OBSTRUCTIVE PULMONARY-DISEASE
  • DOUBLE-BLIND
  • EXACERBATIONS
  • POST-HOC ANALYSIS

Cite this